Literature DB >> 10331820

The impact of first-line antihypertensive drugs on erectile dysfunction.

J D Barksdale1, S F Gardner.   

Abstract

Erectile dysfunction, a problem estimated to affect up to 30 million American men, is associated with a number of systemic illnesses and drugs. Age is not thought to be an independent risk factor for the disorder, but accompanying illnesses and their treatments may contribute to its onset. Newer classes of antihypertensive agents are less frequently associated with sexual dysfunction than diuretics or beta-blockers. However, nearly every first-line antihypertensive drug has been reported to cause some degree of erectile dysfunction. Management options include lifestyle modification, dosage reduction, discontinuation of the offending agent, switching to an alternative drug, and pharmacologic therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331820     DOI: 10.1592/phco.19.8.573.31526

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  8 in total

1.  Four-year review of sildenafil citrate.

Authors:  Andrew R McCullough
Journal:  Rev Urol       Date:  2002

2.  The cumulative effects of medication use, drug use, and smoking on erectile dysfunction among men who have sex with men.

Authors:  Trevor A Hart; David Moskowitz; Christopher Cox; Xiuhong Li; David G Ostrow; Ron D Stall; Pamina M Gorbach; Michael Plankey
Journal:  J Sex Med       Date:  2012-02-09       Impact factor: 3.802

3.  Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israeli men.

Authors:  Arie Roth; Ofra Kalter-Leibovici; Yehuda Kerbis; Ella Tenenbaum-Koren; Juza Chen; Tamar Sobol; Itamar Raz
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

4.  A Randomised Comparison of the Effects of Nebivolol and Atenolol with and without Chlorthalidone on the Sexual Function of Hypertensive Men.

Authors:  Bahar Boydak; Sanem Nalbantgil; Francesco Fici; Istemi Nalbantgil; Mehdi Zoghi; Filiz Ozerkan; Istemihan Tengiz; Ertuğrul Ercan; Hasan Yilmaz; Umit Yoket; Remzi Onder
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

5.  A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice.

Authors:  M P J Nicolai; S S Liem; S Both; R C M Pelger; H Putter; M J Schalij; H W Elzevier
Journal:  Neth Heart J       Date:  2014-01       Impact factor: 2.380

6.  The SAD-MEN questionnaire: a new and reliable questionnaire for assessing sexual dysfunction in Asians with diabetes.

Authors:  C M Chung; M Z H Lu; C Y T Wong; S G K Goh; M I M Azhar; Y M Lim; B N Rusli; B A K Khalid
Journal:  Diabet Med       Date:  2015-10-06       Impact factor: 4.359

7.  Increased risk of testosterone deficiency is associated with the systemic immune-inflammation index: a population-based cohort study.

Authors:  Yongchao Li; Minghui Liu; Yu Cui; Zewu Zhu; Jinbo Chen; Feng Zeng; Meng Gao; Yang Li; Fang Huang; Hequn Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-16       Impact factor: 6.055

8.  Treatment of hypertension among African Americans: the Jackson Heart Study.

Authors:  Jane Harman; Evelyn R Walker; Vicki Charbonneau; Ermeg L Akylbekova; Cheryl Nelson; Sharon B Wyatt
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-01       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.